Stockscreener 앱 받기
59.43
0.17%
0.10
시간 외 거래:
59.12
-0.31
-0.52%
Novo Nordisk Adr 주식(NVO)의 최신 뉴스
Demand for Novo Nordisk's Weight Loss Pill Is Strong Out of the Gate. Is the Stock Due for a Big Rally? - The Motley Fool
Novo Nordisk Before Q4 Earnings: How Should Investors Play the Stock? - Finviz
5 Stocks To Keep an Eye On in 2026, According to Experts - AOL.com
Novo Nordisk’s Wegovy Pill And Akero Deal Reframe Obesity Growth Story - Sahm
Market Trends: What is the next catalyst for ISPCRate Cut & Weekly Setup with ROI Potential - baoquankhu1.vn
Stock Report: Is Novo Nordisk A s b Shares Adrhedged in a consolidation phaseJuly 2025 Highlights & Real-Time Sentiment Analysis - baoquankhu1.vn
Novo Nordisk AS (NVO) Stock Price, Trades & News - GuruFocus
Jim Cramer on Novo Nordisk: "I Think They're Making a Turn Here" - Finviz
Novo Nordisk ADR: Weight?loss Champion Faces High?Altitude Turbulence - AD HOC NEWS
Novo Nordisk Deepens Cell Therapy Push In Canada As Shares Screen Cheap - Sahm
Key facts: Novo Nordisk stock rises 9.12%; expands diabetes partnership; launches Ozempic ad campaign - TradingView
Is Oral Wegovy a Game Changer for Novo Nordisk? - Finviz
Novo Nordisk A/S-Spons ADR (NYSE:NVO) Demonstrates a Strong Dividend Profile Backed by High Profitability - Chartmill
Shorts Report: Can Novo Nordisk A s b Shares Adrhedged be the next market leader - baoquankhu1.vn
Eli Lilly vs. Novo Nordisk: Which Is the Better Stock Buy? - Finviz
Novo Nordisk (NVO) is "in a Battle," Says Jim Cramer - Finviz
Europe’s ADR Index Was Flat, But Single Stocks Were Not - Finimize
Eli Lilly vs Novo Nordisk: Which Company Will Dominate the Weight Loss Drug Market in 2026? - Finviz
Can Novo Nordisk Unseat Eli Lilly as the Weight Loss Drug Leader in 2026? - Finviz
Looking At Novo Nordisk's Recent Unusual Options Activity - Sahm
Can Novo Nordisk A s (b Shares) Adrhedged stock continue upward trendWeekly Loss Report & Daily Risk Controlled Trade Plans - Улправда
Novo Nordisk gets a fresh $73.50 target as Amazon starts selling the Wegovy pill - TechStock²
Novo Nordisk A/S (B Shares) ADRhedged (BATS:NVOH) Trading 0.4% Higher – What’s Next? - Defense World
CICC Initiates Coverage on Novo Nordisk with Outperform Rating and $73.50 Price Target for U.S. ADRBN - marketscreener.com
European ADRs Rose In US Trading As Chip And Pharma Led - Finimize
Will Novo Nordisk A s (b Shares) Adrhedged stock benefit from infrastructure spending2026 world cup usa national team semifinals star players high defensive line winner prediction tactical review - Улправда
Novo Nordisk's Wegovy Weight Loss Pill Hits US Pharmacies With Lower Starting Cost - Sahm
G-Protein Coupled Receptors (GPCRs) Market Size to Hit USD 6.04 Billion by 2032, Growing at a CAGR of 5.59% - GlobeNewswire Inc.
2 Tailwinds Behind Novo Nordisk Stock Heading Into 2026 - Finviz
Jim Cramer Shares Key Caveat For Novo Nordisk (NVO)'s Weight Loss Pill - Finviz
1.78%
0.15%
자본화:
|
볼륨(24시간):